BioCentury
ARTICLE | Company News

Synsorb deal

June 14, 1999 7:00 AM UTC

SYB received an exclusive worldwide license from a consortium to carbohydrate-based compounds that reduce the viscosity of mucus and inhibit the proliferation of bacteria in cystic fibrosis patients. ...